The method section is present, which is unusual enough that I want to make use of it.
I have read the primary source rather than the summary, which has left me with more questions.
I understand the headline. I do not understand the footnotes, and the footnotes look important.
How should I read this, and where are the traps?
The honest answer is that most certificates are silent on it and that the number can be large enough to matter.
Trifluoroacetate has documented biological effects at higher concentrations in cell culture, which is the technical reason acetate exchange exists rather than a marketing one.
| Test | Answers | Does NOT answer |
|---|---|---|
| RP-HPLC, area % | What fraction of detected material is the target | How much target is present |
| Quantified content | Milligrams of peptide per vial | What the impurities are |
| ESI-MS identity | Whether the molecular weight matches | Purity, or isomeric substitution |
| Peptide mapping | Sequence, localised to a fragment | Quantity |
| Karl Fischer | Water content of the solid | Solvent content |
| LAL endotoxin | Pyrogen load in EU/mg | Sterility |
| Sterility test | Growth in defined media over 14 days | Endotoxin, or bioburden count |
The number of basic residues drives counter-ion load, because each protonated basic site pairs with one counter-ion. A sequence with several lysines and arginines carries proportionally more.
Counter-ion content scales with the number of basic residues, following directly from charge balance.
Nothing here is medical advice, and research-use compounds are not approved for human use.
Count the basic residues and you can estimate the counter-ion load.
edited 22 Apr 2026 by mz_4113 — tightened the wording; no substantive change
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse resultsThis is the other half of the reconciliation problem, alongside water content.
Acetate salts are produced by a deliberate ion exchange after purification. The exchange costs a processing step and is the reason acetate-form material is more expensive.
A supplier who reports both water and counter-ion has given you everything needed to reconcile the vial, and on this site that is a very short list.
Net peptide content varies between lots as the process varies, so one figure does not characterise a supplier.
Trifluoroacetate unless a deliberate exchange was done. Ask which.
Start with which counter-ion the process produced, because trifluoroacetate from reverse-phase purification and acetate from a salt exchange behave differently and are quantified differently.
Worked reconciliation: a 10 mg vial at four per cent water and eight per cent trifluoroacetate contains 10.0 × 0.88 = 8.8 mg of peptide, a twelve per cent shortfall against label with a perfectly clean purity figure.
Mechanically, peptides purified by reverse-phase chromatography with a trifluoroacetic acid mobile phase are isolated as trifluoroacetate salts. The trifluoroacetate content depends on the number of basic residues and can run from a few per cent to well over ten by mass on a heavily basic sequence.
Ion chromatography and fluorine NMR are the accepted quantitative methods for trifluoroacetate, and neither is a chromatographic purity method.
The caveat is that a purity figure is completely blind to counter-ion content, and the two are routinely conflated.
Water plus counter-ion is why gross mass and peptide mass differ.
A net-peptide-content figure already accounts for it, which is why net content is the number worth asking for.
Net peptide content — the fraction of gross mass that is the peptide itself — is the figure that folds water and counter-ion together and is what you should ask for if you ask for anything.
Trifluoroacetate effects in cell culture are documented and are the technical basis for salt exchange to acetate.
Ask for net peptide content. It folds water and counter-ion into one usable number.
Acetate is generally preferred to trifluoroacetate for biological work, which is why the exchange is done at all.
Quantification differs by ion: trifluoroacetate by ion chromatography or by fluorine nuclear magnetic resonance, acetate by ion chromatography or by capillary electrophoresis. Neither shows up on a UV chromatogram.
Peptides from reverse-phase purification with trifluoroacetic acid mobile phases are isolated as trifluoroacetate salts, which is standard synthesis practice.
Absence of a counter-ion figure is an absent measurement rather than a low one.
Purity says nothing about counter-ion. They are unrelated measurements.
edited 9 Mar 2026 by loss_on_drying — added the citation requested in comments
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.